Tag Archives: launch

Allergan scores year-end FDA nod for CGRP migraine med Ubrelvy, plans early 2020 launch

The CGRP migraine prevention field already has three meds from Amgen, Eli Lilly and Teva vying for market share, and now Allergan has scored the first approval for an oral CGRP to treat migraines as they happen. Allergan’s Ubrelvy, formerly known as ubrogepant, passed FDA gatekeepers Monday, becoming the first oral CGRP drug for the acute treatment of… Read More »

Sanofi’s Eloctate, a Bioverativ buyout centerpiece, suffers on Roche’s Hemlibra launch

Sanofi has been among the pharma companies hardest hit by U.S. pricing pressure in diabetes, and now, competition is taking a toll on a prized asset from its $ 11.6 billion Bioverativ buyout. In the first quarter, hemophilia drug Eloctate’s sales of €174 missed consensus estimates of €204 million by 14.7%, ODDO BHF analysts wrote in… Read More »